SEAPORT THERAPEUTICS PRESENTS ADDITIONAL PHARMACOKINETIC DATA FROM PHASE 1 CLINICAL TRIAL OF GLYPHAGO™ AT THE 39TH EUROPEAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY (ECNP) CONGRESS

Reuters · 1d ago

Please log in to view news